DV Medical Supply, Inc.

2000 W 135th Street
Gardena, CA. 90249


Nobivac Canine 1-DAPPv + L4 1mL 25/Doses
Nobivac Canine 1-DAPPv + L4 1mL 25/Doses

Nobivac Canine 1-DAPPv + L4 1mL 25/Doses

In Stock.
Part Number:DVM-104667P
  • Disclaimer:This product requires special handling and is shipped Fedex Express Next Day Delivery between 9:00am - 10:30am local time. Customer assumes responsibility if the package is undeliverable for any reason. Address verification and business hours of operation for package receipt is the responsibility of the customer.
MPN: 099336
Manufacturer: Merck Animal Health USA
You need to have an approved DV Med account to order this product.

Provides proven protection against several common viruses and enhanced quality in leptospirosis protection by using the VacciPure™ filtration process.

Canine 1-DAPPV+L4 provides broad-spectrum protection to help keep dogs healthy
Canine Distemper Virus, Canine Adenovirus 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona (inactivated bacterin).

  • Protects against all known strains of canine parvovirus (CPV), including CPV-2c2,3
  • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • High antigenic mass (titer), low passage parvovirus vaccine
  • Overrides maternal antibodies in young puppies
  • The only leptospirosis vaccine to protect and defend against mortality and urinary shedding
  • Prevented mortality caused by 4 virulent Leptospira serovars
  • Protects against adenovirus type 1 that causes hepatitis in dogs
  • Provides disease coverage for commonly spread canine viruses, distemper, adenovirus type 1 (hepatitis), parainfluenza and parvovirus, in 1 formula

Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1, parainfluenza, and parvovirus. Indicated as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa. Prevents leptospiruria associated with L. grippotyphosa, L. canicola, or L. icterohaemorrhagiae. Aids in the prevention of leptospiruria associated with L. pomona. Recommended for use in healthy dogs 8 weeks of age or older.

  • Safety confirmed in 749-dog field study
  • Proven safe across a variety of dog breeds and ages
  • Featuring an even higher level of quality due to VacciPure™ filtration
  • Subcutaneous injection
  • Two 1 mL doses given 2 to 4 weeks apart
  • Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1 mL dose presentation

Related Items